Stratifying ovarian cancer based on AXL signaling for therapeutic targeting

被引：0
|
作者：
Huang, R. Y-J. [1 ]
Antony, J. [1 ]
Tan, T. Z. [1 ]
Low, J. [2 ]
Choolani, M. [3 ]
Thiery, J. P. [1 ]
机构：
[1] Canc Sci Inst Singapore, Singapore, Singapore
[2] Natl Univ Canc Inst, Gynaecol Oncol, Singapore, Singapore
[3] Natl Univ Singapore, Obstet & Gynaecol, Singapore, Singapore
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
基金：
新加坡国家研究基金会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
297O
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Targeting Metabolism of Ovarian Cancer as New Therapeutic Strategy.
    Kudo, Kei
    Ito, Kiyoshi
    Yamada, Hidekazu
    Hiroshi, Shima
    Yaegashi, Nobuo
    Tanuma, Nobuhiro
    REPRODUCTIVE SCIENCES, 2019, 26 : 340A - 340A
  • [42] The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer
    Q Sheng
    J Liu
    British Journal of Cancer, 2011, 104 : 1241 - 1245
  • [43] The Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer
    Kim Moran-Jones
    Molecular Diagnosis & Therapy, 2016, 20 : 199 - 212
  • [44] Targeting AXL for the treatment of pancreatic cancer.
    Ludwig, Kathleen
    Brekken, Rolf A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [45] Targeting growth signaling and metabolic pathways in ovarian cancer cells
    Grunt, T. W.
    ONKOLOGIE, 2013, 36 : 278 - 278
  • [46] Targeting endoplasmic reticulum stress signaling in ovarian cancer therapy
    Yan, Tianqing
    Ma, Xiaolu
    Guo, Lin
    Lu, Renquan
    CANCER BIOLOGY & MEDICINE, 2023, 20 (10) : 748 - 764
  • [47] Targeting endoplasmic reticulum stress signaling in ovarian cancer therapy
    Tianqing Yan
    Xiaolu Ma
    Lin Guo
    Renquan Lu
    Cancer Biology & Medicine, 2023, (10) : 748 - 764
  • [48] Targeting endoplasmic reticulum stress signaling in ovarian cancer therapy
    Tianqing Yan
    Xiaolu Ma
    Lin Guo
    Renquan Lu
    Cancer Biology & Medicine, 2023, 20 (10) : 748 - 764
  • [49] Targeting AXL in platinum-resistant ovarian cancer: from the lab bench to Phase 3 trial
    Fuh, Katherine
    CANCER RESEARCH, 2024, 84 (05)
  • [50] NFKB SIGNALING PATHWAY AS A THERAPEUTIC TARGET IN CHEMORESISTANT OVARIAN CANCER
    Yousefi, H.
    Momeny, M.
    Poursheykhani, A.
    Ghaffari, S. H. A.
    Eyvani, H.
    Zarrinrad, G.
    Barghi, F.
    Sabourinejad, Z.
    Esmaili, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1727 - 1727
12345